A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia

NCT07255846 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped This decision is based solely on internal company prioritization and resource allocation considerations. No patients have been enrolled or dosed in this study and no clinical data have been generated.

Conditions

Interventions

Sponsor

Terremoto Biosciences Inc.